Search

Search Constraints

You searched for: Author/Creator Bergemalm, Daniel

Search Results

1. Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2. (25th February 2022)

2. Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG. (2nd November 2021)

3. Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel Disease. (11th January 2022)

4. Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)*. (3rd July 2017)

5. Orofacial Granulomatosis Associated with Crohn's Disease: a Multicentre Case Series. (8th September 2021)

7. Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study. (July 2021)

8. The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up – an Epi-IBD study. Issue 8 (October 2020)

9. The use of 5‐aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow‐up – an Epi‐IBD study. Issue 8 (1st October 2020)

10. Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register. Issue 7 (14th July 2022)